{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:33:14Z","timestamp":1791405194277,"version":"4.3.3"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1-S10-OD011925-01"],"award-info":[{"award-number":["1-S10-OD011925-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"publisher","award":["R01-DE021058"],"award-info":[{"award-number":["R01-DE021058"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001082","name":"Camille and Henry Dreyfus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001062","name":"Wallace H. Coulter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["R01-AR068249"],"award-info":[{"award-number":["R01-AR068249"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"NIBIB","doi-asserted-by":"publisher","award":["R01-EB012776"],"award-info":[{"award-number":["R01-EB012776"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jconrel.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T10:31:29Z","timestamp":1499509889000},"page":"223-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis"],"prefix":"10.1016","volume":"261","author":[{"given":"Stephen C.","family":"Balmert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3602-099X","authenticated-orcid":false,"given":"Cara","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geza","family":"Erdos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Louis D.","family":"Falo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00018-011-0846-8","article-title":"Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects","volume":"69","author":"Peiser","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0015","series-title":"Patch Testing: Test Concentrations and Vehicles for 4350 Chemicals","author":"De Groot","year":"2008"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/jid.2012.284","article-title":"Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis","volume":"133","author":"Honda","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nri3150","article-title":"Early immune events in the induction of allergic contact dermatitis","volume":"12","author":"Kaplan","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MJT.0b013e31818a975c","article-title":"Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption","volume":"16","author":"Pariser","year":"2009","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1185\/03007990903512156","article-title":"Atopic dermatitis: a review of topical treatment options","volume":"26","author":"Simpson","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1600-0625.2009.00941.x","article-title":"Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function","volume":"19","author":"Kim","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jaad.2005.04.075","article-title":"A systematic review of contact dermatitis treatment and prevention","volume":"53","author":"Saary","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4049\/jimmunol.178.1.605","article-title":"Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis","volume":"178","author":"Ishizaki","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/jid.2012.212","article-title":"The temporal and spatial dynamics of Foxp3+ Treg cell-mediated suppression during contact hypersensitivity responses in a murine model","volume":"132","author":"Lehtimaki","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.4049\/jimmunol.144.11.4121","article-title":"Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion","volume":"144","author":"Gocinski","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0075","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.183.3.1001","volume":"183","author":"Xu","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2007.06.007","article-title":"Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions","volume":"326","author":"Ring","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0095","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/eji.200738109","article-title":"Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg","volume":"38","author":"Horwitz","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0100","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2012.01.013","article-title":"Controlled release formulations of IL-2, TGF-beta1 and rapamycin for the induction of regulatory T cells","volume":"159","author":"Jhunjhunwala","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2008.10.011","article-title":"Delivery of rapamycin to dendritic cells using degradable microparticles","volume":"133","author":"Jhunjhunwala","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11095-012-0916-0","article-title":"Extraction of PLGA-microencapsulated proteins using a two-immiscible liquid phases system containing surfactants","volume":"30","author":"Saez","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/cyto.1995.0054","article-title":"Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII)","volume":"7","author":"Tsang","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0125","doi-asserted-by":"crossref","unstructured":"B. Bediz, E. Korkmaz, R. Khilwani, C. Donahue, G. Erdos, L.D. Falo, Jr., O.B. Ozdoganlar, Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application, Pharm. Res., 31 (2014) 117\u2013135.","DOI":"10.1007\/s11095-013-1137-x"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2012.01.009","article-title":"Influence of PEG in PEG-PLGA microspheres on particle properties and protein release","volume":"81","author":"Buske","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1039\/C5TB00515A","article-title":"Positive charge of \u201csticky\u201d peptides and proteins impedes release from negatively charged PLGA matrices","volume":"3","author":"Balmert","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1039\/b902042j","article-title":"Tuning microcapsules surface morphology using blends of homo- and copolymers of PLGA and PLGA-PEG","volume":"5","author":"Pisani","year":"2009","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/PAP.0b013e31818b1ac6","article-title":"Dermatopathology for the surgical pathologist a pattern-based approach to the diagnosis of inflammatory skin disorders (part II)","volume":"15","author":"Brinster","year":"2008","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.0022-202x.2001.01384.x","article-title":"Interferon-gamma production in skin during contact hypersensitivity. No contribution from keratinocytes","volume":"117","author":"Akiba","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.4049\/jimmunol.173.8.5008","article-title":"Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells","volume":"173","author":"Stephens","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0165","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.176.4.2635","article-title":"Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4(+)CD25(+) T regulatory cells and is dependent on host-derived IL-10","volume":"176","author":"Ghoreishi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coi.2015.05.005","article-title":"Engineering antigen-specific immunological tolerance","volume":"35","author":"Kontos","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2009.03.001","article-title":"Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion","volume":"123","author":"Miyara","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0180","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1073\/pnas.0909384107","article-title":"IL-2\/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25","volume":"107","author":"Letourneau","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0185","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs beta-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0190","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0195","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1073\/pnas.1120611109","article-title":"Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis","volume":"109","author":"Yeste","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0200","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0205","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nnano.2016.135","article-title":"Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles","volume":"11","author":"Kishimoto","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0215","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","article-title":"Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific","volume":"16","author":"Tostanoski","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0220","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrd2653","article-title":"Therapeutic manipulation of immune tolerance in allergic disease","volume":"8","author":"Akdis","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/aging.100496","article-title":"New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53(\u2212\/\u2212) mice by delaying carcinogenesis","volume":"4","author":"Comas","year":"2012","journal-title":"Aging"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0230","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1172\/JCI114932","article-title":"Recombinant latent transforming growth factor-beta-1 has a longer plasma half-life in rats than active transforming growth factor-beta-1, and a different tissue distribution","volume":"86","author":"Wakefield","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0235","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00007890-200405150-00002","article-title":"Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice","volume":"77","author":"Koehl","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jconrel.2017.07.006_bb0240","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20100209","article-title":"IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells","volume":"207","author":"Grinberg-Bleyer","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0245","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/eji.200636207","article-title":"CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue","volume":"36","author":"Ring","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0250","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaci.2009.03.022","article-title":"CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism","volume":"123","author":"Ring","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0255","doi-asserted-by":"crossref","first-page":"15478","DOI":"10.1073\/pnas.0703725104","article-title":"Nitric oxide induces CD4+ CD25+ Foxp3- regulatory T cells from CD4+ CD25- T cells via p53, IL-2, and OX40","volume":"104","author":"Niedbala","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0260","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.4049\/jimmunol.1101398","article-title":"Inducible CD4+ LAP+ Foxp3- regulatory T cells suppress allergic inflammation","volume":"187","author":"Duan","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0265","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.msec.2013.02.020","article-title":"Accelerating protein release from microparticles for regenerative medicine applications","volume":"33","author":"White","year":"2013","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0270","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.0901459","article-title":"Dominant role of antigen dose in CD4+ Foxp3+ regulatory T cell induction and expansion","volume":"183","author":"Turner","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.006_bb0275","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1073\/pnas.0704397104","article-title":"Allograft rejection mediated by memory T cells is resistant to regulation","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917307046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917307046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:51:28Z","timestamp":1692874288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917307046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":55,"alternative-id":["S0168365917307046"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}